Otolith Labs

VeDa’s Virtual Vestibular Conference has kicked off! “Vestibular disorders cause a variety of disorienting and debilitating symptoms such as loss of coordination, vertigo, and dizziness, leaving desperate and confused patients searching for answers.” – Vestibular Disorders Association Register for free to hear from vestibular experts, connect with members of the #vestibular community, and ask your specific questions – all from the comfort of your home. This is a tremendous resource if you or a loved one is seeking answers for inner #ear or #balance disorders. Registration and more information here: https://lnkd.in/gYj494Zc #vertigo

?? Save the date! Vestibular Disorders Association’s Free Annual Virtual Conference is next week, March 3-7, 2025. It's a tremendous live resource for people with inner #ear and #balance disorders. The #free event features live presentations by top #vestibular experts, patient panels, and chat rooms for direct interaction with fellow participants and vestibular patients. Participants will also have the ability to ask the expert speakers questions. Engaging topics include: ‘Beyond Medication: Exploring Alternative Treatments for Vestibular Migraine,’ ‘Thriving in the Real World: Strategies for Navigating Visually Overwhelming Environments with Vestibular Dysfunction,’ and more. Learn more and register here: https://lnkd.in/gYj494Zc

Just published Jan. 22, 2025: “Otolith Labs Announces Data Demonstrating Otolith Technology Effectiveness on Cybersickness from Virtual Reality in Exploratory Study” The newly published exploratory user study investigated the effect of vestibular stimulation on cybersickness from VR experiences. The study demonstrated that subjects utilizing Otolith technology had improved virtual environment experiences with lower reported nausea and longer VR durations. The results indicate that Otolith's vestibular stimulation technology has a positive influence on cybersickness in a provocative virtual environment. Read the full research article here: https://lnkd.in/eyZ5Zp_V Get all the details in the press release here: https://lnkd.in/e_yivMPi

Do you experience vestibular migraines and are curious to learn more about your condition? Kristen Steenerson, MD, shares her expertise and valuable insights on vestibular migraines in her Talk Dizzy to Me interview, “A Dizzy Dive into Vestibular Migraine and PPPD,” interviewed by Abbie Ross, PT, DPT, NCS, and Danielle Tolman, DPT. Dr. Steenerson is a Clinical Assistant Professor of Otolaryngology & Neurology at Stanford University and a valued member of Otolith’s Medical Advisory Board. “I like to set out a scaffolding of three main categories of treatment options that we could work on; I talk about lifestyle changes, talk about physical therapy, and then I talk about medication or devices that could be used. Then, I walk through each one of those categories to see what the level of interest is and make a personalized plan.” – Dr. Steenerson To hear more, listen to the interview here: https://lnkd.in/ekwjkmtQ

For this month’s #teamspotlight, join us in highlighting John Rigol, Otolith’s Senior Director of Quality Assurance & Regulatory Affairs (QARA)! John has over 25 years of experience in Quality & Regulatory for companies such as B. Braun Medical Inc. (US), Abbott, St. Jude Medical, Quest Medical, Inc., and several start-ups. His expertise in managing quality control operations, successfully building ISO 13485 compliant systems, leading executive quality strategies, performing vendor audits, and much more, are invaluable assets to our team. At Otolith, John directs all aspects of our quality management system and plays an integral role in our #regulatory presentation to the Food and Drug Administration (FDA). We are beyond grateful for John's contributions to our team and upcoming FDA submissions!

Yesterday, the Otolith team gathered at our Washington, DC Headquarters for our Annual All-Day All Hands. This year's success is a testament to the hard work, passion, and dedication of each of our team members in advancing the development of the first medical wearable for the treatment of chronic vertigo. Thank you to the entire Otolith team for making 2024 a monumental year. Looking forward to 2025 and another exciting year of growth and innovation!

Samuel Owen, Founder and CEO, and Daniel Wagner, Chief Commercial Officer, join DC Mayor Muriel Bowser for the launch of the exciting new DC Venture Capital Fund in Dupont Circle, DC today! Learn more here: https://lnkd.in/dRv24VAD #VentureCapital

For this month’s #teamspotlight, we are highlighting Otolith Labs’ Biomedical Engineer, Brooke Wilson! Brooke plays a critical role in our clinical studies, providing device management and technical support for all devices utilized. She is also actively involved in testing our #technology, contributing directly to critical improvements and advancements in our #device. At Otolith, Brooke started as a Product Intern, and joined full-time this past June, after graduating from The George Washington University with a Bachelor of Science in Biomedical Engineering with minors in Computer Science and Electrical Engineering. Brooke’s dedication and expertise are a true asset to our device development, and we are lucky to have her on our #team!

Congratulations to Otolith’s #MedicalAdvisoryBoard Member, Jeffrey Sharon, MD, for his publication as a senior author: “Minimal Clinically Important Difference of Vestibular Migraine Patient Assessment Tool and Handicap Inventory (VM-PATHI)”! This pioneering new scale is a validated measure of disease-related suffering specific to patients diagnosed with #vestibular #migraine. VM-PATHI is a tool Otolith uses in our current at-home vestibular migraine study. The patient assessment tool is the first to explicitly address the vestibular migraine population, helping to assess changes in their condition. We’re proud to work with the top #researchers and #clinicians in the vestibular field and honored to work with Dr. Sharon and our MAB to help address the millions of Americans suffering from vestibular migraines. Publication Link: https://lnkd.in/eswEGtSs

What an incredible experience at #MEDICA's Wearable Technology Pavilion last week! Jon Akers, Otolith’s CTO, connected with an extensive range of industry experts, including wearable device companies, design houses, laser welders, and spring suppliers. Jon represents Otolith’s vision as a global corporate leader — developing and providing innovative #vestibular solutions for clinicians and patients worldwide. The extensive program of first-class forums, conferences, and shows provided opportunities for engaging presentations and discussions with experts in the #wearable #technology space. Thank you, MEDICA - Leading International Trade Fair, for a successful event and for helping Otolith expand our industry network in Düsseldorf, Germany & globally!